Matching slides 10,649
Current window 7,921-7,950
Pages 355
Rows per page 30
Arc: Overcoming Monsterclear collectionreset all

Arc

7,921-7,950 of 10,649

filter-aware
83
The slide uses testimonials from a former employee to frame management as incompetent and the product as obsolete.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
84
The slide uses a screenshot of a Nevro investor presentation to expose a contradiction in their reported explant rates.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
85
The slide uses a screenshot of a medical journal article to highlight author conflicts of interest and a table of explant data to challenge the company's claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
86
The slide uses a red circle to highlight a specific table from a medical paper, emphasizing the discrepancy between real-world outcomes and company claims.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
87
The slide uses a series of quotes from KOLs (Key Opinion Leaders) to build a narrative of systemic failure and industry skepticism.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
88
The slide uses direct quotes from a KOL to frame the company's behavior as unethical and retaliatory.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
89
Uses testimonial-style quotes to build a narrative of corporate deception regarding product failure rates.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
90
The slide uses testimonials to build a narrative of industry-wide dissatisfaction and lack of transparency regarding explant data.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
91
The slide uses highlighted quotes to emphasize the severity of the alleged device failures and the high volume of Nevro patients requiring salvage therapy.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
92
Uses highlighted quotes to emphasize negative feedback from medical professionals.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
93
Uses expert testimony to challenge official company data.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
94
Uses testimonial-style quotes from competitor employees to undermine company disclosures.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
95
The slide uses a 'case study' format to provide qualitative evidence of product failure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
96
The slide uses highlighted text to emphasize key negative performance metrics and qualitative feedback.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
97
Case study #3 of 5.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
98
The slide uses highlighted text to emphasize critical data points regarding patient satisfaction and explant rates.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
99
The slide uses highlighted text to emphasize key allegations of fraud and data manipulation.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
100
The slide uses a 'case study' format to expose product failure and corporate ethics issues.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
101
The slide uses highlighted text to emphasize critical claims about medical device safety and physiological impact.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
102
The slide uses a pull-quote to highlight negative sentiment from a key opinion leader.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
103
The slide uses highlighted text to emphasize key negative sentiment regarding Nevro's product reliability and transparency.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
104
The slide uses highlighted text to emphasize critical quotes from a medical professional.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
105
The slide presents a qualitative case study (KOL #5) to support the thesis of widespread device failure.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
106
The slide uses direct quotes from two KOLs to highlight perceived contradictions between their public statements and the reality of device performance.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
107
The slide uses heavy yellow highlighting to emphasize damning statements from anonymous industry experts.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
108
The slide uses direct quotes from former consultants to substantiate claims of corporate misconduct.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
109
The slide uses direct quotes from KOLs to frame the company's management as deceptive and manipulative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
110
The slide uses a direct quote to frame the company's behavior as deceptive.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
111
The slide uses direct quotes from KOLs to frame the company as unethical and manipulative.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit
112
The slide uses highlighted text to emphasize key claims about doctor behavior and financial incentives.Nevro Corp. (NVRO) · Kir Kahlon
Activist deck Short seller Beat · The Victory1 hit